I liked this article from Pharmalot today that tracked Big Pharma's investment in R&D and Manufacturing facilities in the periods 2003-2006 and 2007-2010 respectively and collated the top 10 countries of the world where this occurred for each period. The results are interesting (at least to me).
Follow The Money: Where Pharma Is Investing // Pharmalot.
Top 10 Countries 2003-2006
- USA - $38.7 B
- Ireland - $37.1 B
- Singapore - $27.6 B
- China - $19.7 B
- Germany - $14.8 B
Rounding out the top 10 for this period were Spain, France, Puerto Rico, India and Sweden. Let's look at how the picture has changed over the next period.
Top 10 Countries 2007-2010
- USA - $73.3 B
- China - $29.8 B
- Singapore - $17.7 B
- India - $16.8 B
- Ireland - $16.0 B
Rounding out the top 10 for this period are Italy, Germany, Switzerland, Canada and Brazil. You can see that the Asia-Pacific region is being enriched in the top 10. European countries are dropping on the list, and 4 fell out of the 2007-2010 top 10 though 2 new Euro countries snuck in.
The USA still is the lead country for investment though. Someone please take note. We have a leadership position and it would be a good time to implement policies that helped to cement that lead. European financial issues and controls may be eroding their position as we write -- and Puerto Rico's new tax policy may hasten their further demise as well.
It appears indisputable to me that activity will continue to flow to the East if that's where the new investment in R&D and manufacturing is gaining momentum.
Posted by Bruce Lehr Jan 12th 2012.
Comments